Anzeige
Mehr »
Montag, 20.10.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von pharmaphorum

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
26.09.FDA will review abortion pill safety - will it be impartial?
26.09.BMS adds discounted psoriasis drug to its DTC channel
26.09.Lilly brings second oral SERD to market for breast cancer
26.09.Shock as Trump says 100% pharma tariffs will start on 1 Oct
25.09.Biolinq bags FDA okay for autonomous glucose sensor
25.09.Merck names electronics unit head to replace Garijo as CEO
25.09.Verona Pharma shareholders back $10bn MSD takeover
25.09.AZ takes Medicare negotiation appeal to SCOTUS
25.09.Acadia, Harmony record late-stage rare disease failures
25.09.Moderna opens UK facility as drug pricing spat rumbles on
24.09.Joy as uniQure Huntington's therapy clears pivotal trial
24.09.BMS eyes filings for myeloma 'celmod' iberdomide
24.09.MSD's $345m alliance with Variational, and other AI news
24.09.FDA knocks back Biogen's high-dose Spinraza
24.09.Lilly names Houston as site for $6.5bn API facility
23.09.Manufacturing issues block FDA nod for Scholar Rock SMA drug
23.09.Roche's oral SERD comes good in 2nd-line breast cancer trial
23.09.Angelini taps Sovargen for epilepsy drug in $550m deal
23.09.BMS says it will set Cobenfy's UK price the same as the US
23.09.Alarm as Trump peddles unproven causes of autism
22.09.After internal setbacks, Pfizer buys obesity player Metsera
22.09.Bayer starts pivotal Parkinson's cell therapy trial
22.09.Stealth's patience rewarded as FDA approves Barth drug
22.09.FDA clears subcutaneous Keytruda in a boost to MSD
19.09.Breaking: ACIP pushes back vote on hepatitis B vaccine